Protagenic Therapeutics, Inc.

NasdaqCM:PTIX Stock Report

Market Cap: US$2.9m

Protagenic Therapeutics Past Earnings Performance

Past criteria checks 0/6

Protagenic Therapeutics's earnings have been declining at an average annual rate of -20.1%, while the Biotechs industry saw earnings growing at 19.3% annually.

Key information

-20.1%

Earnings growth rate

-7.1%

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth raten/a
Return on equity-785.5%
Net Marginn/a
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Protagenic Therapeutics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqCM:PTIX Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 240-614
30 Jun 240-615
31 Mar 240-614
31 Dec 230-513
30 Sep 230-413
30 Jun 230-322
31 Mar 230-321
31 Dec 220-422
30 Sep 220-421
30 Jun 220-421
31 Mar 220-531
31 Dec 210-531
30 Sep 210-431
30 Jun 210-431
31 Mar 210-321
31 Dec 200-321
30 Sep 200-321
30 Jun 200-211
31 Mar 200-211
31 Dec 190-211
30 Sep 190-210
30 Jun 190-221
31 Mar 190-321
31 Dec 180-311
30 Sep 180-221
30 Jun 180-221
31 Mar 180-221
31 Dec 170-221
30 Sep 170-220
30 Jun 170-220
31 Mar 170-221
31 Dec 160-210
30 Sep 160-211
30 Jun 160-211
31 Mar 160-210
31 Dec 150-110
30 Sep 150-100
31 Dec 140000

Quality Earnings: PTIX is currently unprofitable.

Growing Profit Margin: PTIX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PTIX is unprofitable, and losses have increased over the past 5 years at a rate of 20.1% per year.

Accelerating Growth: Unable to compare PTIX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PTIX is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (16.6%).


Return on Equity

High ROE: PTIX has a negative Return on Equity (-785.5%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies